A Phase 1b Study to Assess Sitravatinib in Combination With Tislelizumab in Participants With Advanced Solid Tumors
Clinical trial NCT03666143 · COMPLETED
Trial details
- NCT number
- NCT03666143
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-01
- Primary completion
- 2023-01-05
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.